drugset / Trial / NCT06209320

A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

NCT06209320

Phase 3 Active not recruiting 777 enrolled Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized, double-blind, placebo-controlled, multicenter, phase III clinical study of the efficacy and safety of two low-concentration atropine sulfate eye drops in slowing the progression of myopia in children

Timeline

Start
2022-03-15
Primary completion
2025-03-21
Completion
2025-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified Other

Indications